Error: Could not add to watchlist. X
+ Watchlist

Hyperion Therapeutics Inc

HPTX:US
Acquired
HPTX:US was acquired by HZNP:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.85
Market Cap (USD)
-
Shares Outstanding (m)
20.977
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Hyperion Therapeutics Inc. operates as a biopharmaceutical company. The Company develops therapeutics to treat disorders in the areas of orphan diseases and hepatology. Hyperion Therapeutics offers its services throughout the United States.
Address
2000 Sierra Point Parkway
Suite 400
Brisbane, CA 94005
United States
Phone
1-650-745-7802
Show More